Markets:

Overview

News

Currencies

International

Treasuries

Sangamo Therapeutics, Inc. - Common Stock (NQ:SGMO)

0.4166 -0.0034 (-0.81%)

Streaming Delayed Price Updated: 11:55 AM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Sangamo Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs ↗

October 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...

Via Benzinga

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO ↗

August 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...

Via Benzinga

The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results ↗

October 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

The Daily Biotech Pulse: Adcom Tryst For Pfizer/BioNTech Booster Shot, AbCellera's COVID Antibody Treatment Gets Expanded Use, Protagonist Slapped With Clinical Hold ↗

September 17, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 16) Bicycle Therapeutics plc (...

Via Benzinga

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

August 31, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

Stocks That Hit 52-Week Lows On Friday ↗

August 20, 2021

On Friday morning, 155 companies achieved new lows for the year. Interesting Points: Marqeta (NASDAQ:MQ) was the largest firm on a market cap basis to set a new 52-...

Via Benzinga

Sangamo Therapeutics Announces Participation at 2021 Wedbush PacGrow Healthcare Conference

August 09, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data ↗

August 20, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 19) Alkermes plc (NASDAQ: ALKS...

Via Benzinga

Sangamo Therapeutics, inc (SGMO) Q2 2021 Earnings Call Transcript ↗

August 06, 2021

SGMO earnings call for the period ending June 3, 2021.

Via The Motley Fool

Topics Earnings

Sangamo Therapeutics Reports Recent Business Highlights and Second Quarter 2021 Financial Results

August 05, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics Announces Second Quarter 2021 Conference Call and Webcast

July 29, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 21, 2021

Gainers Adial Pharmaceuticals (NASDAQ:ADIL

Via Benzinga

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs ↗

August 01, 2021

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....

Via Benzinga

Sangamo Therapeutics Appoints Prathyusha Duraibabu, CPA, MBA, to Chief Financial Officer

May 24, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics Announces Participation at Jefferies Healthcare Conference

May 21, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics Inc (SGMO) Q1 2021 Earnings Call Transcript ↗

May 05, 2021

SGMO earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Sangamo Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results

May 04, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2021 ↗

May 04, 2021

Upgrades For Genuine Parts Co (NYSE:GPC), Goldman Sachs upgraded the previous rating of Sell to Neutral. In the first quarter, Genuine Parts showed an EPS of $1.50,...

Via Benzinga

Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

May 03, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

Sangamo Therapeutics Announces Presentations at 2021 Annual Meeting of the American Society of Gene & Cell Therapy

April 27, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data ↗

May 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 3) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Earnings Scheduled For May 4, 2021 ↗

May 04, 2021

Companies Reporting Before The Bell • Lancaster Colony (NASDAQ:LANC) is likely to report quarterly earnings at $1.24 per share on revenue of $340.02 million. •...

Via Benzinga

Sangamo Therapeutics Announces First Quarter 2021 Conference Call and Webcast

April 27, 2021

From Sangamo Therapeutics, Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.